BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33529294
Number of visits today
5562
Number of downloads
16715381
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Zhao JZ, Ye Q, Wang L, Lee SC. Centrosome amplification in cancer and cancer-associated human diseases. Biochim Biophys Acta Rev Cancer 2021;1876:188566. [PMID: 33992724 DOI: 10.1016/j.bbcan.2021.188566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao ML, Wang JX, Bian XK, Zhang J, Han YW, Xu SX, Lee SC, Zhao JZ. Hexavalent chromium causes centrosome amplification by inhibiting the binding between TMOD2 and NPM2. Toxicol Lett 2023:S0378-4274(23)00112-1. [PMID: 36963620 DOI: 10.1016/j.toxlet.2023.03.008] [Reference Citation Analysis]
2 Steiert B, Faris R, Weber MM. In Search of a Mechanistic Link between Chlamydia trachomatis-Induced Cellular Pathophysiology and Oncogenesis. Infect Immun 2023;91:e0044322. [PMID: 36695575 DOI: 10.1128/iai.00443-22] [Reference Citation Analysis]
3 Zhao ML, Wang JX, Bian XK, Zhang J, Han YW, Xu SX, Lee SC, Zhao JZ. Hexavalent chromium causes centrosome amplification by inhibiting the binding between TMOD2 and NPM2.. [DOI: 10.21203/rs.3.rs-2173707/v1] [Reference Citation Analysis]
4 Jinna N, Jovanovic-Talisman T, LaBarge M, Natarajan R, Kittles R, Sistrunk C, Rida P, Seewaldt VL. Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention. Cancers (Basel) 2022;14:4484. [PMID: 36139643 DOI: 10.3390/cancers14184484] [Reference Citation Analysis]
5 Xu SX, Han YW, Guo JL, Bian XK, Hu HM, Lee SC. The binding between NPM and H2B proteins signals for the diabetes-associated centrosome amplification. Cell Biochem Funct 2022. [PMID: 35678289 DOI: 10.1002/cbf.3721] [Reference Citation Analysis]
6 Huang RL, Liu C, Fu R, Yan Y, Yang J, Wang X, Li Q. Downregulation of PLK4 expression induces apoptosis and G0/G1-phase cell cycle arrest in keloid fibroblasts. Cell Prolif 2022;:e13271. [PMID: 35670224 DOI: 10.1111/cpr.13271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yan X, Liu SM, Liu C. Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect. Onco Targets Ther 2022;15:1355-68. [PMID: 36388157 DOI: 10.2147/OTT.S380016] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345